Antibe closes C$4 million follow-on

On June 21, pain and inflammation company Antibe Therapeutics Inc. (TSX-V:ATE; OTCQX:ATBPF) raised C$4 million ($3.1 million) through the sale of 40.5 million units at C$0.10 in the first close of a follow-on. Bloom Burton, Dominick and Echelon Wealth are agents for the financing...